After Yesterday’s Announcement Of An Agreement, Biolase Has Made A Spectacular Climb

By Staff of Admiral Markets

Wednesday, January 13, 2021 8:34 AM EDT

Biolase Inc. (BIOL), an American Nasdaq-listed medical device company that manufactures and markets proprietary dental laser devices which enable dentists to perform a wide range of procedures, ranging from surgical and restorative operations to the simple and non-invasive.

Yesterday, Biolase announced that it has reached an agreement with DSO Dental Care Alliance to extend the use and management of its lasers in dental offices in the United States.

DSO Dental Care is one of the most important dentist organizations in the United States, with a presence in more than 20 states. It is expected that this agreement will significantly increase Biolase sales, which, up to now, has sold more than 41,200 dental laser systems in more than 80 countries around the world.

After the announcement of this important agreement, the price of this company experienced a spectacular rise of more than 80% during the trading day, exceeding 1.10 dollars per share, with a close at around a dollar per share, easily overcoming its previous resistance levels at 0.66, 0.80 and 0.93 dollars per share.

Technically speaking, after this strong rise, the price is very far from its moving averages with its stochastic indicator approaching its overbought zone, so it would not be ruled out that the price could make some correction in the form of taking profits in the next sessions, although the signing of this agreement gives impetus to this action, since in the coming weeks the triple crossing of moving averages can be completed with the upward crossing of its medium-term moving average in orange to the moving average of 200 sessions in red.

(Click on image to enlarge)

Source: Admiral Markets MetaTrader 5. Biolase daily chart. Data range: from September 12, 2019 to January 13, 2021. Prepared on January 13, 2021 at 10:30 am CET. Keep in mind that past returns do not guarantee future returns.

BIOL performance over the last five years:

2020: -24.60%

2019: -44.17%

2018: -53.56%

2017: -69.54%

2016: 66.44%

Disclaimer: The given data provides additional information regarding all analysis, estimates, prognosis, forecasts or other similar assessments or information (hereinafter "Analysis") ...

Disclaimer: The given data provides additional information regarding all analysis, estimates, prognosis, forecasts or other similar assessments or information (hereinafter "Analysis") published on the website of Admiral Markets. Before making any investment decisions please pay close attention to the following:

This is a marketing communication. The content is published for informative purposes only and is in no way to be construed as investment advice or recommendation. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research, and that it is not subject to any prohibition on dealing ahead of the dissemination of investment research.

Any investment decision is made by each client alone whereas Admiral Markets Group AS investment firms (Admiral Markets) shall not be responsible for any loss or damage arising from any such decision, whether or not based on the content.

The Analysis is prepared by an independent analyst (hereinafter "Author") based on the Author's personal estimations.

To ensure that the interests of the clients would be protected and objectivity of the Analysis would not be damaged Admiral Markets has established relevant internal procedures for prevention and management of conflicts of interest.

Whilst every reasonable effort is taken to ensure that all sources of the content are reliable and that all information is presented, as much as possible, in an understandable, timely, precise and complete manner, Admiral Markets does not guarantee the accuracy or completeness of any information contained within the Analysis.

Any kind of past or modeled performance of financial instruments indicated within the content should not be construed as an express or implied promise, guarantee or implication by Admiral Markets for any future performance. The value of the financial instrument may both increase and decrease and the preservation of the asset value is not guaranteed.

Leveraged products (including contracts for difference) are speculative in nature and may result in losses or profit. Before you start trading, you should make sure that you understand all the risks.

less

How did you like this article? Let us know so we can better customize your reading experience.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.